0000950170-23-029609.txt : 20230623 0000950170-23-029609.hdr.sgml : 20230623 20230623160800 ACCESSION NUMBER: 0000950170-23-029609 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230615 FILED AS OF DATE: 20230623 DATE AS OF CHANGE: 20230623 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HASTINGS DAVID C CENTRAL INDEX KEY: 0001237401 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36365 FILM NUMBER: 231037740 MAIL ADDRESS: STREET 1: C/O ARBUTUS BIOPHARMA STREET 2: 100-8900 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SCYNEXIS INC CENTRAL INDEX KEY: 0001178253 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562181648 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 EVERTRUST PLAZA STREET 2: 13TH FLOOR CITY: JERSEY CITY STATE: NJ ZIP: 07302-6548 BUSINESS PHONE: 201-884-5485 MAIL ADDRESS: STREET 1: 1 EVERTRUST PLAZA STREET 2: 13TH FLOOR CITY: JERSEY CITY STATE: NJ ZIP: 07302-6548 4 1 ownership.xml 4 X0407 4 2023-06-15 0001178253 SCYNEXIS INC SCYX 0001237401 HASTINGS DAVID C 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 true false Common Stock 2023-06-15 4 A false 10000 0.00 A 23183 D One-hundred percent (100%) of the shares subject to the restricted stock unit vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date. /s/ Robert F. Joyce Jr. 2023-06-23